Description

3,4-Dihydro-3-Oxo-4-β-D-Ribofuranosyl-2-Pyrazinecarboxamide is a specialized nucleoside analog with significant potential in pharmaceutical research and development. This compound is valued for its role as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. It is primarily required by research institutions and pharmaceutical companies engaged in antiviral, anticancer, and metabolic disorder drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of nucleoside-based antiviral and anticancer drugs.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies to understand metabolic pathways and mechanisms of action.
• Antiviral Agent Development: Investigated for its potential activity against a range of viral targets due to its modified ribose and heterocyclic base structure.
• Preclinical & Clinical Studies: Employed in the formulation of drug candidates for pharmacokinetic, pharmacodynamic, and toxicology evaluations.
• Reference Standard: Utilized as a high-purity analytical standard for quality control and method validation in pharmaceutical analysis.
• Academic Research: Applied in university and institutional labs for fundamental research in medicinal chemistry and chemical biology.

Basic Information

Product Name	3,4-Dihydro-3-Oxo-4-β-D-Ribofuranosyl-2-Pyrazinecarboxamide
CAS No.	356782-84-8
Molecular Formula	C10H13N3O6
Molecular Weight	271.23 g/mol
Synonyms	4-β-D-Ribofuranosyl-3,4-dihydro-3-oxo-2-pyrazinecarboxamide; 2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-4-β-D-ribofuranosyl-; 4-(β-D-Ribofuranosyl)-3,4-dihydro-3-oxo-2-pyrazinecarboxamide; 4-(β-D-Ribofuranosyl)-3-oxo-3,4-dihydro-2-pyrazinecarboxylic acid amide; Ribofuranosylpyrazinecarboxamide; Nucleoside Pyrazinecarboxamide Derivative
EINECS	Contact for details

Quality Control

Our 3,4-Dihydro-3-Oxo-4-β-D-Ribofuranosyl-2-Pyrazinecarboxamide is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing all specifications are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.